103550-76-1 Usage
General Description
2-Azetidinemethanamine, also known as 1-Azetidineethanamine, is a chemical compound with the molecular formula C3H8N2. It is a colorless, water-soluble liquid with a faint ammonia-like odor. 2-Azetidinemethanamine is primarily used in organic synthesis, but it also has potential applications in the pharmaceutical industry as a building block for the synthesis of various biologically active compounds. In addition, it may have potential as a reagent for the preparation of N-protected amino acids and peptide coupling reagents. 2-Azetidinemethanamine has not been widely studied for its safety and potential hazards, so it is important to handle and use it with caution in a controlled laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 103550-76-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,5,5 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 103550-76:
(8*1)+(7*0)+(6*3)+(5*5)+(4*5)+(3*0)+(2*7)+(1*6)=91
91 % 10 = 1
So 103550-76-1 is a valid CAS Registry Number.
InChI:InChI=1/C4H10N2/c5-3-4-1-2-6-4/h4,6H,1-3,5H2
103550-76-1Relevant articles and documents
Synthesis and antitumor activities of platinum complexes of unsymmetrical alicyclic diamines as carrier ligands
Morikawa,Honda,Endoh,Matsumoto,Akamatsu,Mitsui,Koizumi
, p. 750 - 753 (1990)
The synthesis and biological activities of the platinum complexes of 2-aminomethylaziridine, 2-aminomethylazetidine, 2-aminomethylpyrrolidine, and 2-aminomethylpiperidine as carrier ligands are described. The platinum complexes of 2-aminomethylazetidine and 2-aminomethylpyrrolidine are significantly effective against murine tumors. In particular, 2-aminomethylazetidine (1,1-cyclobutanedi-carboxyplato)platinum II (13) and 2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum II (16) exhibited potent antitumor activity and were soluble in water, and their antitumor activities against Colon 26 carcinoma (sc-ip system) were superior to CBDCA and comparable to CDDP.
